- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
Becoming a Patient in Wisconsin
In 2014, Wisconsin passed AB 726, which creates a legal right for patients with seizure disorders to possess and use CBD-rich medicines if they have a written recommendation. The law allows medical practitioners to dispense CBD but provides no clear guidance on how they may obtain it, nor does the law address production or distribution. The law only removes criminal penalties for CBD and does not authorize the possession or use of THC in any quantity. Nearly all CBD-rich products have at least some amount of THC, making the production of qualifying medicine practically impossible.
The law allows physicians and pharmacies to dispense CBD that is free of THC, but does not provide guidance on how physicians or pharmacies would obtain the substance, except that the controlled substances board of the state shall assist physicians in acquiring CBD through investigation new drug programs.
The only eligible condition in Wisconsin is seizure disorders.
There is no application process to become a patient under AB 726. A physician's written recommendation is all that necessary for a patient to be legally allowed to possess and administer CBD products under AB 726; however, there is not clear way for patients to obtain such products.
Any doctor treating a patient for seizure disorders can recommend to a patient. There is no requirement on the nature of the patient-physician relationship.
Caregivers are not permitted under AB 726.
The law is silent on where patients may consumer their medicine.
The law does not contain any restrictions pertaining to a patient's age.
The law does not have any specific confidentiality provisions; however, there is no patient registry, and a physician’s medical records of a patient are protected under HIPPA.
The law does not contain any housing protections for patients.
The law does not contain any employment protections for patients.
Insurance is not addressed in the law, but it is unlikely at this time that any health insurer will cover CBD products.
Out of State Patients
The law does not require a patient or a recommending physician be a Wisconsin resident. However, an out of state patient ID card will only protect a patient in Wisconsin if they have a recommendation for a seizure disorder, and they may not possess products with any THC.
For More Information